论文部分内容阅读
两种利凡诺(40mg/kg)制剂(“水剂”和“合剂”)雌兔腹腔注射,72h后的SGPT和BUN与用药前比较,均无显著差异(P>0.05);肝肾组织亦无明显病理改变。腹腔内大剂量利凡诺并不明显引起肝肾功能和形态损害。如利凡诺“合剂”用于宫腔内抗早孕时,即使利凡诺完全进入腹腔内也还是安全的
There was no significant difference in SGPT and BUN between two kinds of rifano (40mg / kg) preparations (“water” and “mixture” No obvious pathological changes. Intra-abdominal large doses of rivanol does not significantly cause liver and kidney function and morphological damage. Such as rivanol “mixture” for intrauterine anti-conception, even if Rivanol completely into the abdominal cavity is still safe